Gliatech (GLIA) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gliatech (GLIA)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Torben Noerup Nielsen who wrote (1387)	2/27/2000 4:24:00 PM
From: jeffbas	Read Replies (3) of 2001

Torben, I don't own the stock so have no bias. The latest 10Q (and perhaps earlier ones) I believe mentioned a patient lawsuit. The NYU person claimed on YAHOO that they no longer use Adcon (because of the potential risk of excessive scarring if there are minor surgical tears?). If this is factually accurate, the two are related, and the lawsuit is not frivolous - then it seems to me there could be a problem. In my opinion, the only rational explanation for the large increase in short interest in the last month AFTER the FDA problem was resolved is conviction that there is a potentially serious problem. However, I would remind the shorts of the Bob Wilson experience with Resorts International 20 or so years ago, in the most highly publicized short squeeze in history. He was totally right with his fundamental view and got killed when the stock went up 10 times in a massive short squeeze, before collapsing to where he expected it to go in the first place.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next